DSTU2 QA Preview

This page is part of the FHIR Specification (v1.0.0: DSTU 2 Ballot 3). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3 R2

Medicationdispenseexample8

This is the narrative for the resource. See also the XML or JSON format.

Capecitabine (Recurrent/Metastatic)

Course:

Name: Capecitabine

Agent Protocols Options:

Capecitabine 1000-1250 mg/m^2 PO twice daily D1-14

Offset: None

Cycle length: Q21D

 

 

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.